Linderane
CAS No. 13476-25-0
Linderane( Linderane | )
Catalog No. M17966 CAS No. 13476-25-0
Linderane was characterized as a mechanism-based inactivator of CYP2C9.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 58 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 287 | In Stock |
|
| 100MG | 428 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLinderane
-
NoteResearch use only, not for human use.
-
Brief DescriptionLinderane was characterized as a mechanism-based inactivator of CYP2C9.
-
DescriptionLinderane is a cytochrome P450 2C9 inhibitor from Lindera aggregata (Sims).
-
In Vitro——
-
In Vivo——
-
SynonymsLinderane |
-
PathwayOthers
-
TargetOther Targets
-
RecptorCYP2C9
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number13476-25-0
-
Formula Weight260.28
-
Molecular FormulaC15H16O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (384.19 mM)
-
SMILESCC1=CCCC23C(O2)C(C4=C(C1)OC=C4C)OC3=O
-
Chemical Name(10S,10aS,E)-5,9-dimethyl-3,6,10,10a-tetrahydro-2H-10,1a-(epoxymethano)oxireno[2',3':4,5]cyclodeca[1,2-b]furan-12-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
3-Chloro-L-Tyrosine
3-Chlorotyrosine a specific marker of myeloperoxidase-catalyzed oxidation is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima. In particular myeloperoxidase halogenates tyrosine residues in plasma proteins and generates 3-chlorotyrosine (CY).
-
Isoguvacine hydrochl...
Isoguvacine hydrochloride is a GABA receptor agonist. Isoguvacine hydrochloride binds to rat synaptic cortical membranes and activates α1β2γ2S, α2β2γ2S, α3β2γ2S, α5β2γ2S, and ρ1 subunit GABAA receptors.
-
SH-42
SH-42 is a human Δ24-dehydrocholesterol reductase (DHCR24) inhibitor (IC50: 42 nM) that is selective and highly potent in inducing an increase in plasma desmethylferricinol levels.
Cart
sales@molnova.com